Key takeaways
Prezista (darunavir) and Crixivan (indinavir) are both protease inhibitors used to treat HIV, but they have some key differences. Prezista (darunavir) is still available and commonly used, while Crixivan (indinavir) has been discontinued in the U.S. due to low demand and the availability of newer treatments. Prezista (darunavir) must be taken with a booster like ritonavir (Norvir) and food to be effective, whereas Crixivan (indinavir) did not have this requirement. Prezista (darunavir) is available as both a tablet and an oral suspension, making it easier for those who have trouble swallowing pills. Additionally, Prezista (darunavir) can be used in children as young as 3 years old and is considered safe during pregnancy, while Crixivan (indinavir) had more limitations and side effects, which contributed to its decline in use. Lastly, Prezista (darunavir) requires regular blood tests to monitor liver health and interactions with other medications, highlighting the need for careful management.
